A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00230529
Recruitment Status : Completed
First Posted : October 3, 2005
Last Update Posted : June 9, 2011
Information provided by:
Centocor, Inc.